As an NCI-designated Comprehensive Cancer Center, we have access to some of the most innovative clinical trials in the United States. In some cases, these are new chemo-therapeutic agents; in some cases, it’s new surgical techniques. All of these clinical trials allow us to fundamentally improve patient care through discovery and science.
Ilana Cass, MD, Chair, Department of Obstetrics and Gynecology
Intensely focused on improving patient outcomes as well as patient experience, the Gynecologic Cancer Program at Dartmouth Cancer Center offers multidisciplinary care. Receiving treatment at one of three NCI-designated Comprehensive Cancer Centers in New England provides access to life-changing clinical trials, research and cutting-edge treatments. Studies show that receiving cancer care at an NCI-designated site can increase survival rates by up to 25%.
Our gynecologic cancer surgeons use robotic surgical techniques that allow for absolute precision, often making surgeries safer and less invasive. Patients also typically experience a faster recovery. Patients in the Gynecologic Cancer Program have an entire team of experts helping them navigate their care efficiently and with empathy and compassion.